These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20119648)

  • 21. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease.
    Shibata M; Morita Y; Shimizu T; Takahashi K; Suzuki N
    J Neurol Sci; 2009 Jan; 276(1-2):79-83. PubMed ID: 18838148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease.
    Oka H; Morita M; Onouchi K; Yoshioka M; Mochio S; Inoue K
    J Neurol Sci; 2007 Mar; 254(1-2):72-7. PubMed ID: 17306830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease.
    Haensch CA; Lerch H; Jörg J; Isenmann S
    Parkinsonism Relat Disord; 2009 Feb; 15(2):134-7. PubMed ID: 18515170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular dysautonomia in de novo Parkinson's disease.
    Oka H; Mochio S; Onouchi K; Morita M; Yoshioka M; Inoue K
    J Neurol Sci; 2006 Feb; 241(1-2):59-65. PubMed ID: 16325862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
    Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
    Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.
    Choi MH; Yoon JH; Yong SW
    J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson's disease.
    Ryu DW; Yoo SW; Choi KE; Oh YS; Kim JS
    J Neurol; 2024 Mar; 271(3):1397-1407. PubMed ID: 37940708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate variability and sympathetic skin response for the assessment of autonomic dysfunction in leucine-rich repeat kinase 2 associated Parkinson's disease.
    Nasri A; Kacem I; Farhat N; Gharbi A; Sakka S; Souissi A; Zidi S; Damak M; Bendjebara M; Gargouri A; Mhiri C; Gouider R
    Neurophysiol Clin; 2022 Feb; 52(1):81-93. PubMed ID: 35058123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of patients with Parkinson's disease with reduced
    Ebina J; Mizumura S; Morioka H; Shibukawa M; Nagasawa J; Yanagihashi M; Hirayama T; Ishii N; Kobayashi Y; Inaba A; Orimo S; Kano O
    J Neurol Sci; 2024 Mar; 458():122932. PubMed ID: 38401301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of a card-type odor identification test to olfactory assessment in Parkinson's disease.
    Homma H; Yoritaka A; Hattori N; Kobayakawa T; Ikeda K
    Auris Nasus Larynx; 2013 Apr; 40(2):173-6. PubMed ID: 22824520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
    Yamashita F; Hirayama M; Nakamura T; Takamori M; Hori N; Uchida K; Hama T; Sobue G
    Clin Auton Res; 2010 Jun; 20(3):191-7. PubMed ID: 20127386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.